SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950123-09-000991
Filing Date
2009-01-22
Accepted
2009-01-22 16:49:14
Documents
3
Group Members
BOXFORD SUBSIDIARY CORPORATION

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D y74141sc13d.htm SC 13D 90408
2 EX-99.2: FORM OF STOCKHOLDER AGREEMENT y74141exv99w2.htm EX-99.2 44385
3 EX-99.3: JOINT FILING AGREEMENT y74141exv99w3.htm EX-99.3 3341
  Complete submission text file 0000950123-09-000991.txt   140121
Mailing Address
Business Address 8 CAMPUS DRIVE PARSIPPANY NJ 07054 973-656-1616
MEDICINES CO /DE (Filed by) CIK: 0001113481 (see all company filings)

IRS No.: 043324394 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 222 THIRD AVENUE SUITE 2300 CAMBRIDGE MA 02142
Business Address 222 THIRD AVENUE SUITE 2300 CAMBRIDGE MA 02142 (617) 557-9020
Targanta Therapeutics Corp. (Subject) CIK: 0001398161 (see all company filings)

IRS No.: 203971077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-83189 | Film No.: 09539629
SIC: 2834 Pharmaceutical Preparations